REGN holders · GOLDMAN SACHS GROUP INC 13F · REGN stock
GOLDMAN SACHS GROUP INC Regeneron Pharmaceuticals Inc (REGN) 13F holding
GOLDMAN SACHS GROUP INC reported 762,859 REGN shares valued at $589.42B as of 2026-03-31 (CMN). Cached 13F row, not a live tape.
| Report | Shares | Value | Class |
|---|---|---|---|
| 2026-03-31 | 762,859 | $589.42B | CMN |
| 2026-03-31 | 505,840 | $390.83B | CMN |
| 2026-03-31 | 187,600 | $144.95B | Call |
| 2026-03-31 | 20,620 | $15.93B | CMN |
| 2026-03-31 | 16,500 | $12.75B | Put |
| 2026-03-31 | 6,576 | $5.08B | CMN |
| 2026-03-31 | 2,544 | $1.97B | CMN |
| 2026-03-31 | 1,631 | $1.26B | CMN |
| 2026-03-31 | 488 | $377.0M | CMN |
Not investment advice. Cached 13F row, not EDGAR XML.